Dr. Dash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1536 N 115th St
Seattle, WA 98133Phone+1 206-668-5215Fax+1 206-668-5214- Is this information wrong?
Summary
- I'm a Urologic Oncologist with expertise in laparoscopic, robotic and open surgery interested in academic positions.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2004 - 2007
University of Michigan Health SystemResidency, Urology, 1998 - 2004- University of Michigan Health SystemInternship, Transitional Year, 1998 - 1999
University of Vermont College of MedicineClass of 1998
Certifications & Licensure
WA State Medical License 2013 - 2026
CA State Medical License 2007 - 2025
NY State Medical License 2004 - 2009
MI State Medical License 1998 - 2006- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Chart Review of Laparoscopic Radical Cystectomy Start of enrollment: 2005 Dec 01
- Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy Start of enrollment: 2008 Oct 01
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.Jonathan L Wright, Jeannette M Schenk, Roman Gulati, Sarah J Beatty, Matthew VanDoren, Daniel W Lin, Michael P Porter, Colm Morrissey, Atreya Dash, John L Gore, Ruth E...> ;Cancer. 2024 Feb 14
- 3 citationsA Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.Dimitrios Makrakis, Jonathan L Wright, Martine P Roudier, Jose Garcia, Funda Vakar-Lopez, Michael P Porter, Yan Wang, Atreya Dash, Daniel Lin, George Schade, Brian Win...> ;Clinical Genitourinary Cancer. 2023 Apr 1
- 3 citationsDietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.Jeannette M Schenk, Menghan Liu, Marian L Neuhouser, Lisa F Newcomb, Yingye Zheng, Kehao Zhu, James D Brooks, Peter R Carroll, Atreya Dash, William J Ellis, Christophe...> ;Nutrition and Cancer. 2023 Jan 1
- Join now to see all
Journal Articles
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Atreya Dash, JAMA Oncology
Authored Content
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityAugust 2020
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityAugust 2020
- Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes SurveyMarch 2019
Press Mentions
Comorbidities Should Be Factor in Prostate Biopsy Choice, UCI Study FindsFebruary 10th, 2016
Professional Memberships
- Member
- Member
- Society of Urologic OncologyMember
Hospital Affiliations
Seattle VA Medical CenterSeattle, Washington
UW Medicine/Northwest Hospital & Medical CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
UW Medicine/Harborview Medical CenterSeattle, Washington
UW Medicine/Valley Medical CenterRenton, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
